Literature DB >> 27476665

Functional Heterogeneity of Nadph Oxidases in Atherosclerotic and Aneurysmal Diseases.

Yasuyoshi Kigawa1, Takuro Miyazaki, Xiao-Feng Lei, Joo-Ri Kim-Kaneyama, Akira Miyazaki.   

Abstract

NADPH oxidases (NOX) are enzymes that catalyze the production of reactive oxygen species (ROS). Four species of NOX catalytic homologs (NOX1, NOX2, NOX4, and NOX5) are reportedly expressed in vascular tissues. The pro-atherogenic roles of NOX1, NOX2, and their organizer protein p47ph°x were manifested, and it was noted that the hydrogen peroxide-generating enzyme NOX4 possesses atheroprotective effects. Loss of NOX1 or p47ph°x appears to ameliorate murine aortic dissection and subsequent aneurysmal diseases; in contrast, the ablation of NOX2 exacerbates the aneurysmal diseases. It is possible that the loss of NOX2 activates inflammatory cascades in macrophages in the lesions. Roles of NOX5 in vascular functions are currently undetermined, owing to the absence of this enzyme in rodents and the limitation of the experimental procedure. Thus, it is possible that the NOX family of enzymes exhibits heterogeneity in the atherosclerotic diseases. In this aspect, subtype-selective NOX inhibitor may be promising when NOX systems serve as a molecular target for atherosclerotic and aneurysmal diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27476665      PMCID: PMC5225127          DOI: 10.5551/jat.33431

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  95 in total

1.  The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells.

Authors:  Junya Kuroda; Kazunori Nakagawa; Tomoko Yamasaki; Kei-ichiro Nakamura; Ryu Takeya; Futoshi Kuribayashi; Shinobu Imajoh-Ohmi; Kazuhiko Igarashi; Yosaburo Shibata; Katsuo Sueishi; Hideki Sumimoto
Journal:  Genes Cells       Date:  2005-12       Impact factor: 1.891

Review 2.  Why have antioxidants failed in clinical trials?

Authors:  Steven R Steinhubl
Journal:  Am J Cardiol       Date:  2008-05-22       Impact factor: 2.778

Review 3.  Testing endothelial function and its clinical relevance.

Authors:  Pavel Poredos; Mateja Kaja Jezovnik
Journal:  J Atheroscler Thromb       Date:  2012-09-10       Impact factor: 4.928

4.  NADPH oxidase deficiency exacerbates angiotensin II-induced abdominal aortic aneurysms in mice.

Authors:  Yasuyoshi Kigawa; Takuro Miyazaki; Xiao-Feng Lei; Tomoya Nakamachi; Tatsunori Oguchi; Joo-ri Kim-Kaneyama; Matsuo Taniyama; Shohko Tsunawaki; Seiji Shioda; Akira Miyazaki
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-09-04       Impact factor: 8.311

5.  Ruptured abdominal aortic aneurysm in a well-defined geographic area.

Authors:  M Heikkinen; J-P Salenius; O Auvinen
Journal:  J Vasc Surg       Date:  2002-08       Impact factor: 4.268

Review 6.  Nox proteins in signal transduction.

Authors:  David I Brown; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

7.  Atorvastatin limits the pro-inflammatory response of rat aortic smooth muscle cells to thrombin.

Authors:  Mounsif Haloui; Olivier Meilhac; Martine Jandrot-Perrus; Jean Baptiste Michel
Journal:  Eur J Pharmacol       Date:  2003-08-08       Impact factor: 4.432

Review 8.  NADPH oxidases: functions and pathologies in the vasculature.

Authors:  Bernard Lassègue; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311

9.  Expression of NAD(P)H oxidase subunits and their contribution to cardiovascular damage in aldosterone/salt-induced hypertensive rat.

Authors:  Young Mee Park; Bong Hee Lim; Rhian M Touyz; Jeong Bae Park
Journal:  J Korean Med Sci       Date:  2008-12-24       Impact factor: 2.153

10.  The NADPH oxidase Nox4 has anti-atherosclerotic functions.

Authors:  Christoph Schürmann; Flavia Rezende; Christoph Kruse; Yakub Yasar; Oliver Löwe; Christian Fork; Bart van de Sluis; Rolf Bremer; Norbert Weissmann; Ajay M Shah; Hanjoong Jo; Ralf P Brandes; Katrin Schröder
Journal:  Eur Heart J       Date:  2015-09-17       Impact factor: 29.983

View more
  6 in total

Review 1.  Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of the NADPH Oxidase NOX1-5 and Superoxide Dismutase 1-3 Signal Transduction Pathways.

Authors:  Alessia Parascandolo; Mikko O Laukkanen
Journal:  Antioxid Redox Signal       Date:  2018-11-22       Impact factor: 8.401

Review 2.  Dysregulation of Calpain Proteolytic Systems Underlies Degenerative Vascular Disorders.

Authors:  Takuro Miyazaki; Akira Miyazaki
Journal:  J Atheroscler Thromb       Date:  2017-08-17       Impact factor: 4.928

Review 3.  Cardiac Cell Senescence and Redox Signaling.

Authors:  Daniela Cesselli; Aneta Aleksova; Sandro Sponga; Celeste Cervellin; Carla Di Loreto; Gianluca Tell; Antonio Paolo Beltrami
Journal:  Front Cardiovasc Med       Date:  2017-05-29

Review 4.  Reactive Oxygen Species (ROS), Intimal Thickening, and Subclinical Atherosclerotic Disease.

Authors:  Denise Burtenshaw; Michael Kitching; Eileen M Redmond; Ian L Megson; Paul A Cahill
Journal:  Front Cardiovasc Med       Date:  2019-08-02

5.  Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice.

Authors:  Arief Rahadian; Daiju Fukuda; Hotimah Masdan Salim; Shusuke Yagi; Kenya Kusunose; Hirotsugu Yamada; Takeshi Soeki; Masataka Sata
Journal:  J Atheroscler Thromb       Date:  2020-02-26       Impact factor: 4.928

Review 6.  Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis.

Authors:  Anastasia V Poznyak; Nikita G Nikiforov; Alexander M Markin; Dmitry A Kashirskikh; Veronika A Myasoedova; Elena V Gerasimova; Alexander N Orekhov
Journal:  Front Pharmacol       Date:  2021-01-11       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.